期刊文献+

脂蛋白相关磷脂酶A2基因A379V多态性与TOAST亚型的关系 被引量:3

Association between Lp-PLA2 Gene A379V Polymorphism and TOAST Classification
下载PDF
导出
摘要 目的探讨脂蛋白相关磷脂酶A2(lipoprotein associated phospholipase A2,Lp-PLA2)血清水平及其基因A379V多态性与低分子肝素实验病因分型(the trial of Org 10172 in acute stroke treatment,TOAST)的关系。方法对急性期脑梗死患者(N=200)和对照组(体检中心健康体检者,N=172)应用酶联免疫吸附法(enzyme linked immunosorbent assay,ELISA)检测血清Lp-PLA2水平,聚合酶链反应(polymerasechain reaction,PCR)及基因测序技术检测基因多态性。结果脑梗死组血清Lp-PLA2水平(24.39±6.63)ng/ml,高于对照组(15.78±4.32)ng/ml,差异有显著性(P<0.01);TOAST分型后比较,大动脉粥样硬化性梗死(large artery atherosclerotic stroke,LAA)组、小动脉闭塞性梗死(small artery occlusion stroke,SAO)组、对照组血清Lp-PLA2水平分别是(25.60±6.71)ng/ml、(21.43±5.47)ng/ml、(15.78±4.32)ng/ml,差异有显著性(P<0.01);脑梗死组惠者,Lp-PLA2基因A379V多态性位点CC基因型频率68%,C等位基因频率83%,与对照组的70.9%、84.3%比较,差异无显著性(P>0.05),但是TOAST分型后显示CC纯合子血清Lp-PLA2水平(26.27±6.25)ng/ml较T等位基因携带者(CT+TT)(20.39±5.64)ng/ml发生脑梗死的风险增加(P<0.01)。结论 Lp-PLA2血清水平在脑梗死组升高,LAA组升高最明显;A379V基因多态性CC基因型与脑梗死的发病可能相关。 Objective To explore the relationship between the serum lipoprotein phospholipase A2(Lp- PLA2) level and its gene A379V polymorphism and the trial of Org 10172 in acute stroke treatment(TOAST) subtypes of cerebral infarction. Methods The serum Lp-PLA2 level in 200 patients with acute cerebral infarction and 172 healthy controls were measured by Enzyme linked immunosorbent assay(ELISA). Polymerase chain reaction(PCR) and direct sequencing assay were used to detect gene polymorphism. Results The serum Lp-PLA2 level of the patients (24.39±6.63)ng/ml was higher than that in healthy controls (15.78±4.32)ng/ml, there was a significant difference(P〈0.01). According to TOAST classification, we found that serum Lp-PLA2 level was significant different among large artery atherosclerotic stroke(LAA) group (25.60±6.71)ng/ml, small artery occlusion stroke(SAO) group (21.43±5.47)ng/ml and healthy controls (15.78±4.32)ng/ml(P〈0.01). Among the patients, the CC genotype frequency was 68%,the C allele frequency was 83%,compared with the healthy controls(CC genotype frequency was 68%,C was 83%), there was no difference(P〉0.05). However, the serum Lp-PLA2 level of the CC homozygote (26.27±6.25)ng/ml had significantly higher stroke risk compared with the T allele carriers(CT+TT) (20.39±5.64)ng/ml(P〈0.01).Conclusion The serum Lp-PLA2 level in the cerebral infarction increased, LAA group was the most obvious; Maybe A3 79V polymorphism CC genotype had relationship with stroke.
出处 《中国卒中杂志》 2012年第11期858-863,共6页 Chinese Journal of Stroke
关键词 脂蛋白相关磷脂酶A2 基因多态性 脑梗死 TOAST分型 Lipoprotein associated phospholipase A2 Gene polymorphism Cerebral infarction TOAST classification
  • 相关文献

参考文献24

  • 1Cao J J, Thach C, Manolio TA, et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly:The Cardiovascular Health Study[J]. Circulation, 2003, 108:166-170.
  • 2Hashimoto H, Kitagawa K, Hougaku H, et al. C-reactive protein is an independent predictor of the rate of increase in early carotid atherosclerosis[J]. Circulation, 2001, 104:63-67.
  • 3Stoll G, Bendszus M. Inflammation and atherosclerosis:novel insights into plaque formation and destabilization[J]. Stroke, 2006, 37:1923-1932.
  • 4Quarck R, De Geest B, Stengel D, et al. Adenovirus- mediated gene transfer of human platelet-activting factor-acetylhydrolase prevents injury-induced neointima formation and reduces spontaneous atherosclerosis in apolipoprotein E-deficient mice[J]. Circulation, 2001, 103:2495-2500.
  • 5Leach CA, Hickey DM, Ire R J, et al. Lipoprotein- associated PLA2 inhibition--a novel,nonlipid lowering strategy for atherosclerosis therapy[J]. Farmaco, 2001, 56:45 -50.
  • 6吴延华,曹勇军,刘慧慧,陈冬勤,朱雪明,刘春风.急性脑梗死患者血清脂蛋白相关磷脂酶A2活性的变化[J].中华神经科杂志,2008,41(6):381-382. 被引量:16
  • 7Wootton PT, Stephens JW, Hurelb S J, et al. Lp-PLA2 activity and PLA2G7 A379V genotype in patients with diabetes mellitus[J]. Atherosclerosis, 2006, 189:149-156.
  • 8Abuzeid AM, Hawe E, Humphries SE, et al. Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe[J]. Atherosclerosis, 2003, 168:283-288.
  • 9Niniol E, Tregouet D, Carrier JL, et al. Platelet- activating factor-acetylhydrolase and PAF-receptor gene haplotypes in relation to future cardiovascular event in patients with coronary artery disease[J]. Hum Mol Genet, 2004, 13:1341-1351.
  • 10Jang Y, Kim OY, Koh S J, et al. The Va1279Phe Variant of the lipoprotein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men[J]. J Clin Endocrinol Metab, 2006, 91:3521-3527.

二级参考文献30

  • 1各类脑血管疾病诊断要点[J].中华神经科杂志,1996,29(6):379-380. 被引量:33024
  • 2罗光华,郑璐,张晓膺,许国锋,朱江,牟琴峰,魏江,陈陆俊,张俊,徐宁.ShineRoar探针技术检测单核苷酸多态性[J].中华检验医学杂志,2007,30(6):609-612. 被引量:8
  • 3Stafforini DM, Tjoelker LW, McCormick SP, et al. Molecular basis of the interaction between plasma platelet-activating factor acetylhydrolase and low density lipoprotein. J Biol Chem, 1999, 274:7018-7024.
  • 4Zalewski A, Macphee CH. Role of lipoprotein-associated phospholipase A2 in atherosclerosis : biology, epidemiology, and possible therapeutic. Arterioscler Thromb Vase Biol, 2005, 25 : 923 -931.
  • 5Macphee CH, Nelson J, Zalewski A. Role of lipoproteinassociated phospholipase A2. in atherosclerosis and its potential as a therapeutic target. Currt Opin Pharmacol,2006, 6 : 154-161.
  • 6O' Donoghue M, Morrow DA, Sabatine MS, et al. Lipoproteinassociated phospholipase A2 and its association with cardiovascular outcomes in patients with acute coronary syndromes in the PROVE IT-TIMI 22 ( PRavastatin Or atorVastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction) trial. Circulation, 2006, 113: 1745-1752.
  • 7Tsimihodimos V, Karabina SA, Tambaki AP, et al. Atorvastatin preferentially reduces LDL-associated platelet-activating factor acetylhydrolase activity in dyslipidemias of type Ⅱ A and type Ⅱ B. Arterioscler Thromb Vasc Biol, 2002, 22: 306-311.
  • 8Koenig W, Khuseyinova N, Lowel H, et al. Lipoprotein-associated phos- pholipase A2 adds to risk prediction of incident coronary events by C- reactive protein in apparently healthy middle-aged men from the general population:results from the 14-year follow-up of a large cohort from southern Germany. Circulation, 2004,110 : 1903-1908.
  • 9Abuzeid AM, Hawe E, Humphries SE, et al. Association between the Ala379Val variant of the lipoprotein associated phospholipase A2 and risk of myocardial infarction in the north and south of Europe. Atherosclerosis ,2003,168:283-288.
  • 10Jang Y,Kim OY,Koh SJ,et al. The Val279Phe variant of the lipopro- tein-associated phospholipase A2 gene is associated with catalytic activities and cardiovascular disease in Korean men. The Journal of clinical endocrinology and metabolism ,2006,91:3521-3527.

共引文献339

同被引文献32

  • 1McCullough PA.Darapladib and athemselerotic plaque: should lipoprotein-associated phospholipase A2 be a ther- apeutic target?[J].Curr Atheroscler Rep,2009,11 (5) : 334- 337.
  • 2Jenny NS, Solomon C, Cushman M, et al.Lipoprotein-asso- ciated phospholipase A2 (Lp-PLA2)a and risk of cardio- vascular disease in older adults:results from the Cardio- vascular Health Study [J].Atherosclerosis, 2010,209 (2) : 528-532.
  • 3Stafforini DM.Biology of platelet-activating factor acetyl- hydrolase (PAF-AH,lipoprotein associated phospholipase A2)[J].Cardiovasc Drugs Ther, 2009,23 (1) : 73-83.
  • 4Vickers KC,Maguire CT,Wolfert R.Relationship of lipopro- tein associated phospholipase A2 and oxidized low density lipoprotein in carotid atherosclerosis[J].J Lipid Ras,2009, 50(9): 1735-1743.
  • 5Sanchen-Quesada JL,Vinagre I,Juan-Fronco ED,et al. Effect of improving glycemic control in patients with type 2 diabetes mellitus on low-density lipoprotein size,elec- tronegative iow-density lipoprotein and lipoprotein-asso- ciated phospholipase A2 distribution[J].Am J Cardiol,2012, 11(~( 1 ) : 67-71.
  • 6Vittos O, Toana B, Vittos A,et al.Lipoprotein-associated phospholipase A2(Lp-PLA2):a review of its role and sig- nificance as a cardiovascular biomarker[J].Biomarkers, 2012,17(4) : 289-302.
  • 7Dohi T,Miyauchi K,Ohkawa R.Increased lysophospha- tidic acid levels in culprit coronary arteries of patients with acute coronary syndrome[J].Atherosclerosis, 2013,229 (1) : 192-197.
  • 8李青芳,梁江红,邓胜玲.脂蛋白相关磷脂酶A2与脑梗死患者颈动脉不稳定粥样斑块的关系[J].实用医学杂志,2009,25(2):224-226. 被引量:28
  • 9何正初,梅徽.老年腔隙性脑梗死与血脂相关性研究[J].临床和实验医学杂志,2010,9(1):18-18. 被引量:6
  • 10弗恩德,庄稼英(编译).脂质分子内表型或可预测糖尿病和心脏病?[J].糖尿病天地(临床),2011(5):196-197. 被引量:2

引证文献3

二级引证文献11

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部